首页> 外文OA文献 >The Development and Validation of a Prognostic Nomogram and Nomogram Application Software Among Men Treated with Abiraterone Acetate and/or Enzalutamide for Metastatic Castration-resistant Prostate Cancer

【2h】

The Development and Validation of a Prognostic Nomogram and Nomogram Application Software Among Men Treated with Abiraterone Acetate and/or Enzalutamide for Metastatic Castration-resistant Prostate Cancer

机译：对醋酸盐和/或依甲酰胺进行转移阉割前列腺癌治疗预后NOM图和吲哚图申请软件的开发和验证

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takashi Kawahara; Yusuke Saigusa; Shuko Yoneyama; Masashi Kato; Ippei Kojima; Hiroshi Yamada; Osamu Kamihira; Kenichi Tabata; Hideyasu Tsumura; Masatsugu Iwamura; Masahiro Yao; Hiroji Uemura; Yasuhide Miyoshi;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer [J] . Yun-Jie Yang, Guo-Wen Lin, Gao-Xiang Li, Asian journal of andrology . 2018,第2期

机译：外部验证和诺模图的新开发，以预测阿比特龙治疗，去势抵抗性转移性前列腺癌患者的总体生存
2. Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center Experience [J] . Chang Li-Wen, Hung Sheng-Chun, Wang Shian-Shiang, Anticancer Research: International Journal of Cancer Research and Treatment . 2019,第7期

机译：AbiraTerone醋酸盐和烯醇酰胺：在治疗后的多西紫杉醇转移性阉割前列腺癌症中的类似疗效：单一中心经验
3. Antitumour Activity and Safety of Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Abiraterone Acetate Plus Prednisone for = 24 weeks in Europe [J] . de Bono Johann S., Chowdhury Simon, Feyerabend Susan, European urology . 2018,第1期

机译：先前用AbiraTerone醋酸盐加上抗泼尼松治疗的转移阉割前列腺癌患者依齐甲酰胺的抗肿瘤活性和安全性。欧洲24周
4. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer [C] . Jiangdian Song, Yali Zang, Weimin Li, Conference on Computer-Aided Diagnosis . 2017

机译：放射组学诺模图的开发和验证，用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
5. Development and Validation of a Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy for Breast Cancer. [D] . Yang, Victoria Qi. 2015

机译：诺法图的开发和验证，以预测对乳腺癌新辅助化学疗法的病理完全反应。
6. External validation and newly development of a nomogram to predict overall survival of abiraterone-treated castration-resistant patients with metastatic prostate cancer [O] . Yun-Jie Yang, Guo-Wen Lin, Gao-Xiang Li, 2018

机译：外部验证和诺模图的新开发以预测阿比特龙治疗去势抵抗性转移性前列腺癌患者的总体生存
7. A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide [O] . D.P. Petrylak, U.N. Vaishampayan, K.R. Patel, 2021

机译：含镭-223二氯化钠或与AbiraTerone醋酸盐/泼尼松或苯甲酸丁酰胺组合处理的转移阉割抗性前列腺癌（MCRPC）的量化骨扫描响应的随机相IIA研究

The Development and Validation of a Prognostic Nomogram and Nomogram Application Software Among Men Treated with Abiraterone Acetate and/or Enzalutamide for Metastatic Castration-resistant Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅